JP2010518946A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010518946A5 JP2010518946A5 JP2009550618A JP2009550618A JP2010518946A5 JP 2010518946 A5 JP2010518946 A5 JP 2010518946A5 JP 2009550618 A JP2009550618 A JP 2009550618A JP 2009550618 A JP2009550618 A JP 2009550618A JP 2010518946 A5 JP2010518946 A5 JP 2010518946A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- scaffold material
- osteonecrosis
- pdgf
- biocompatible matrix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims description 47
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 claims description 26
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 claims description 26
- 239000011159 matrix material Substances 0.000 claims description 22
- 239000000463 material Substances 0.000 claims description 20
- 206010031264 Osteonecrosis Diseases 0.000 claims description 19
- 230000005855 radiation Effects 0.000 claims description 14
- 208000029985 osteonecrosis of the jaw Diseases 0.000 claims description 11
- 210000000988 bone and bone Anatomy 0.000 claims description 10
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 8
- 239000011230 binding agent Substances 0.000 claims description 6
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 6
- 239000001506 calcium phosphate Substances 0.000 claims description 6
- 235000011010 calcium phosphates Nutrition 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 5
- 108010081589 Becaplermin Proteins 0.000 claims description 3
- 102000008186 Collagen Human genes 0.000 claims description 3
- 108010035532 Collagen Proteins 0.000 claims description 3
- 229920001436 collagen Polymers 0.000 claims description 3
- 210000002805 bone matrix Anatomy 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims 5
- 241000186046 Actinomyces Species 0.000 claims 2
- 241000238631 Hexapoda Species 0.000 claims 2
- 230000001934 delay Effects 0.000 claims 2
- 230000036512 infertility Effects 0.000 claims 2
- 210000004400 mucous membrane Anatomy 0.000 claims 2
- 230000001338 necrotic effect Effects 0.000 claims 2
- 230000035699 permeability Effects 0.000 claims 2
- 239000011148 porous material Substances 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 208000024891 symptom Diseases 0.000 claims 2
- 230000005012 migration Effects 0.000 claims 1
- 238000013508 migration Methods 0.000 claims 1
- 238000000034 method Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 2
- 239000008351 acetate buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89076307P | 2007-02-20 | 2007-02-20 | |
| PCT/US2008/054354 WO2008103690A2 (en) | 2007-02-20 | 2008-02-20 | Prevention and treatment for osteonecrosis and osteoradionecrosis of the jaw using pdgf and a bone matrix |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010518946A JP2010518946A (ja) | 2010-06-03 |
| JP2010518946A5 true JP2010518946A5 (enExample) | 2011-04-07 |
Family
ID=39710710
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009550618A Pending JP2010518946A (ja) | 2007-02-20 | 2008-02-20 | 顎の骨壊死および顎の放射線骨壊死の予防および処置 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20100151025A1 (enExample) |
| EP (1) | EP2125000A2 (enExample) |
| JP (1) | JP2010518946A (enExample) |
| AU (1) | AU2008218763B2 (enExample) |
| CA (1) | CA2678875A1 (enExample) |
| WO (1) | WO2008103690A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7473678B2 (en) * | 2004-10-14 | 2009-01-06 | Biomimetic Therapeutics, Inc. | Platelet-derived growth factor compositions and methods of use thereof |
| US7799754B2 (en) | 2004-10-14 | 2010-09-21 | Biomimetic Therapeutics, Inc. | Compositions and methods for treating bone |
| EP2431060B1 (en) | 2005-11-17 | 2020-04-08 | BioMimetic Therapeutics, LLC | Maxillofacial bone augmentation using RHPDGF-BB and a biocompatible matrix |
| US9161967B2 (en) | 2006-06-30 | 2015-10-20 | Biomimetic Therapeutics, Llc | Compositions and methods for treating the vertebral column |
| ES2664229T3 (es) * | 2006-06-30 | 2018-04-18 | Biomimetic Therapeutics, Llc | Composiciones y métodos de biomatriz-PDGF para el tratamiento de lesiones del manguito rotador |
| JP5552315B2 (ja) | 2006-11-03 | 2014-07-16 | バイオミメティック セラピューティクス， エルエルシー | アースロデティック術のための組成物および方法 |
| WO2009100454A1 (en) * | 2008-02-07 | 2009-08-13 | Biomimetic Therapeutics, Inc. | Compositions and methods for distraction osteogenesis |
| JP5966129B2 (ja) * | 2011-01-31 | 2016-08-10 | オリンパス株式会社 | 免疫賦活剤 |
| CA2962954A1 (en) | 2014-10-14 | 2016-04-21 | Samuel Lynch | Compositions for treating wounds |
| GB2549714A (en) * | 2016-04-25 | 2017-11-01 | Pharmaceutical Business Consultants Ltd | Vascularity affinity precursor structure for musculo-skeletal tissue healing |
| JP7117724B2 (ja) * | 2018-01-18 | 2022-08-15 | 新田ゼラチン株式会社 | 歯肉および歯槽粘膜の再生促進作用に基づく顎骨壊死、顎骨骨髄炎または抜歯後治癒不全の予防に用いる予防剤 |
| WO2025024276A1 (en) * | 2023-07-21 | 2025-01-30 | Mercury Bio, Inc. | Production and delivery of therapeutic nucleic acids packaged in yeast extracellular vesicles embedded in biocompatible implant matrices |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1260391A (en) * | 1985-03-28 | 1989-09-26 | Karl A. Piez | Xenogeneic collagen/mineral preparations in bone repair |
| DE4120325A1 (de) * | 1991-06-20 | 1992-12-24 | Merck Patent Gmbh | Implantatwerkstoff |
| US5614206A (en) * | 1995-03-07 | 1997-03-25 | Wright Medical Technology, Inc. | Controlled dissolution pellet containing calcium sulfate |
| JP4809963B2 (ja) * | 1999-11-11 | 2011-11-09 | オリンパス株式会社 | 骨補填材 |
| JP2003019195A (ja) * | 2000-05-19 | 2003-01-21 | Mmt:Kk | 生体用部材 |
| EP1483298A4 (en) * | 2002-02-11 | 2007-03-14 | Zymogenetics Inc | MATERIALS AND METHODS FOR PREPARING DIMERED GROWTH FACTORS |
| EP1501357A4 (en) * | 2002-05-06 | 2009-10-21 | Genentech Inc | USE OF VEGF FOR THE TREATMENT OF BONE DEFECTS |
| ATE418619T1 (de) * | 2002-06-14 | 2009-01-15 | Pierce Biotechnology Inc | Homogenes assay zum nachweis von enzymaktivität |
| JP2004159971A (ja) * | 2002-11-14 | 2004-06-10 | Hideki Yoshikawa | 骨形成用部材およびその製造方法 |
| EP1433489A1 (en) * | 2002-12-23 | 2004-06-30 | Degradable Solutions AG | Biodegradable porous bone implant with a barrier membrane sealed thereto |
| JPWO2004105825A1 (ja) * | 2003-01-10 | 2006-07-20 | 多木化学株式会社 | 骨形成用生体材料、該材料を含む注入用製剤、及び該材料を調製するためのキット、並びにこれらを用いる骨形成方法 |
| CA2516113A1 (en) * | 2003-02-13 | 2004-08-26 | Synthes (U.S.A.) | Injectable bone-replacement mixture |
| ES2569780T3 (es) * | 2003-06-27 | 2016-05-12 | DePuy Synthes Products, Inc. | Células posparto derivadas de tejido placentario y métodos de preparación y uso de las mismas |
| WO2005009468A1 (ja) * | 2003-07-25 | 2005-02-03 | Ono Pharmaceutical Co., Ltd. | 軟骨関連疾患治療剤 |
| JP2005111130A (ja) * | 2003-10-10 | 2005-04-28 | Olympus Corp | 骨補填材の製造方法 |
| WO2005067942A1 (en) * | 2004-01-16 | 2005-07-28 | Institute Of Nutraceutical Research Pty Ltd | Glycosaminoglycan peptides derived from connective tissues and use thereof in the prevention of arthritis and other degenerative medical conditions |
| US7799754B2 (en) * | 2004-10-14 | 2010-09-21 | Biomimetic Therapeutics, Inc. | Compositions and methods for treating bone |
| US7473678B2 (en) * | 2004-10-14 | 2009-01-06 | Biomimetic Therapeutics, Inc. | Platelet-derived growth factor compositions and methods of use thereof |
| JP2006320442A (ja) * | 2005-05-18 | 2006-11-30 | Toshiba Ceramics Co Ltd | リン酸カルシウム系骨補填材 |
| EP2431060B1 (en) * | 2005-11-17 | 2020-04-08 | BioMimetic Therapeutics, LLC | Maxillofacial bone augmentation using RHPDGF-BB and a biocompatible matrix |
| US7833270B2 (en) * | 2006-05-05 | 2010-11-16 | Warsaw Orthopedic, Inc | Implant depots to deliver growth factors to treat osteoporotic bone |
| ES2664229T3 (es) * | 2006-06-30 | 2018-04-18 | Biomimetic Therapeutics, Llc | Composiciones y métodos de biomatriz-PDGF para el tratamiento de lesiones del manguito rotador |
| US9161967B2 (en) * | 2006-06-30 | 2015-10-20 | Biomimetic Therapeutics, Llc | Compositions and methods for treating the vertebral column |
| JP5552315B2 (ja) * | 2006-11-03 | 2014-07-16 | バイオミメティック セラピューティクス， エルエルシー | アースロデティック術のための組成物および方法 |
| WO2008100442A1 (en) * | 2007-02-09 | 2008-08-21 | Biomet Biologics, Inc. | Treatment of tissue defects with a therapeutic composition |
| JP2010536851A (ja) * | 2007-08-22 | 2010-12-02 | ステムニオン，インコーポレイテッド | 新規の細胞性因子含有溶液組成物 |
| WO2009100454A1 (en) * | 2008-02-07 | 2009-08-13 | Biomimetic Therapeutics, Inc. | Compositions and methods for distraction osteogenesis |
| NZ602861A (en) * | 2008-09-09 | 2014-03-28 | Biomimetic Therapeutics Llc | Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries |
| US20100196347A1 (en) * | 2008-12-19 | 2010-08-05 | Vladimir Kery | Bone grafts with reduced protease activity and methods of selection and use |
| JP2012519556A (ja) * | 2009-03-05 | 2012-08-30 | バイオミメティック セラピューティクス， インコーポレイテッド | 骨軟骨欠損を治療するための血小板由来増殖因子組成物および方法 |
-
2008
- 2008-02-20 AU AU2008218763A patent/AU2008218763B2/en not_active Ceased
- 2008-02-20 CA CA002678875A patent/CA2678875A1/en not_active Abandoned
- 2008-02-20 US US12/527,692 patent/US20100151025A1/en not_active Abandoned
- 2008-02-20 JP JP2009550618A patent/JP2010518946A/ja active Pending
- 2008-02-20 EP EP08743499A patent/EP2125000A2/en not_active Withdrawn
- 2008-02-20 WO PCT/US2008/054354 patent/WO2008103690A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Anwandter et al. | Dimensional changes of the post extraction alveolar ridge, preserved with Leukocyte-and Platelet Rich Fibrin: A clinical pilot study | |
| Alzahrani et al. | Influence of platelet rich fibrin on post-extraction socket healing: A clinical and radiographic study | |
| Ewers | Maxilla sinus grafting with marine algae derived bone forming material: a clinical report of long-term results | |
| Célio-Mariano et al. | Comparative radiographic evaluation of alveolar bone healing associated with autologous platelet-rich plasma after impacted mandibular third molar surgery | |
| Le et al. | Screw “tent-pole” grafting technique for reconstruction of large vertical alveolar ridge defects using human mineralized allograft for implant site preparation | |
| Froum et al. | Effect of platelet-rich plasma on bone growth and osseointegration in human maxillary sinus grafts: three bilateral case reports | |
| Rosen et al. | The treatment of intrabony defects with bone grafts. | |
| Kurkcu et al. | Anorganic bovine-derived hydroxyapatite vs β-tricalcium phosphate in sinus augmentation: a comparative histomorphometric study | |
| Horowitz et al. | Bone grafting: history, rationale, and selection of materials and techniques. | |
| Kaul et al. | Autologous platelet rich plasma after third molar surgery: a comparative study | |
| Merkx et al. | Reconstruction of the mandible using preshaped 2.3 mm titanium plates, autogenous particulate cortico-cancellous bone grafts and platelet rich plasma: a report on eight patients | |
| Kattimani et al. | Socket preservation using eggshell-derived nanohydroxyapatite with platelet-rich fibrin as a barrier membrane: a new technique | |
| JP2010518946A (ja) | 顎の骨壊死および顎の放射線骨壊死の予防および処置 | |
| JP5674196B2 (ja) | ヒドロキシアパタイト（ｈｙｄｒｏｐａｔｉｔｅ）上の多孔性生体材料 | |
| Kesmas et al. | Esthetic alveolar ridge preservation with calcium phosphate and collagen membrane: preliminary report | |
| Matsui et al. | Bone regeneration by octacalcium phosphate collagen composites in a dog alveolar cleft model | |
| Bavetta et al. | The use of human allogenic graft (HBA) for maxillary bone regeneration: review of literature and case reports | |
| Figliuzzi et al. | Biomimetic hydroxyapatite used in the treatment of periodontal intrabony pockets: clinical and radiological analysis | |
| Eldibany et al. | The effect of Nanobone® in combination with platelet rich fibrin on bone regeneration following enucleation of large mandibular cysts | |
| Macedo et al. | Bone integration behavior of hydroxyapatite/β-tricalcium phosphate graft implanted in dental alveoli: A histomorphometric and scanning electron microscopy study | |
| Mooren et al. | Reconstruction of the mandible using preshaped 2.3-mm titanium plates, autogenous cortical bone plates, particulate cancellous bone, and platelet-rich plasma: a retrospective analysis of 20 patients | |
| Muñoz-Corcuera et al. | Post-extraction application of beta-tricalcium phosphate in alveolar socket | |
| Alraei et al. | Application of Recombinant Human BMP‐2 with Bone Marrow Aspirate Concentrate and Platelet‐Rich Fibrin in Titanium Mesh for Vertical Maxillary Defect Reconstruction prior to Implant Placement | |
| Kudyar et al. | The effects of autologous platelet concentrate on the healing of intra-bony defects: a randomized clinical trial | |
| Lal et al. | Biomaterials in periodontal osseous defects |